Certara (NASDAQ:CERT) Shares Gap Up - Here's What Happened

Certara, Inc. (NASDAQ:CERT - Get Free Report)'s share price gapped up prior to trading on Friday . The stock had previously closed at $14.25, but opened at $15.18. Certara shares last traded at $15.15, with a volume of 689,656 shares.

Analysts Set New Price Targets

A number of brokerages have weighed in on CERT. Barclays lowered their target price on Certara from $14.00 to $12.00 and set an "equal weight" rating for the company in a report on Thursday, November 7th. Robert W. Baird lowered their price objective on shares of Certara from $18.00 to $13.00 and set a "neutral" rating for the company in a research note on Tuesday, November 5th. Six research analysts have rated the stock with a hold rating and two have given a buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of "Hold" and a consensus target price of $15.92.

Certara Trading Down 1.1 %

The business has a fifty day moving average of $12.20 and a 200-day moving average of $11.65. The company has a debt-to-equity ratio of 0.28, a quick ratio of 2.86 and a current ratio of 2.86. The company has a market capitalization of $2.26 billion, a P/E ratio of -70.15, a PEG ratio of 9.33 and a beta of 1.57.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of the business. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its holdings in shares of Certara by 16.8% during the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 263,574 shares of the company's stock valued at $2,807,000 after buying an additional 37,870 shares during the last quarter. Voloridge Investment Management LLC boosted its stake in Certara by 269.3% during the 4th quarter. Voloridge Investment Management LLC now owns 275,633 shares of the company's stock valued at $2,935,000 after purchasing an additional 201,003 shares during the last quarter. Squarepoint Ops LLC boosted its stake in Certara by 62.7% during the 4th quarter. Squarepoint Ops LLC now owns 94,433 shares of the company's stock valued at $1,006,000 after purchasing an additional 36,386 shares during the last quarter. Two Sigma Advisers LP increased its holdings in Certara by 35.7% during the 4th quarter. Two Sigma Advisers LP now owns 87,500 shares of the company's stock worth $932,000 after purchasing an additional 23,000 shares in the last quarter. Finally, Two Sigma Investments LP raised its stake in shares of Certara by 20.1% in the fourth quarter. Two Sigma Investments LP now owns 377,524 shares of the company's stock worth $4,021,000 after purchasing an additional 63,246 shares during the last quarter. Institutional investors and hedge funds own 73.96% of the company's stock.

Certara Company Profile

Certara, Inc, together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solution used to predict both pharmacokinetics and pharmacodynamics.